(EMAILWIRE.COM, April 03, 2019 ) According to research report the report the Vaccine Adjuvants Market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016 at a CAGR of 10.5% from 2016 to 2021.
The vaccine adjuvants market is consolidated in nature due to the presence of a few large players. Prominent players in the vaccine adjuvants market include Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc., and OZ Biosciences (France).
Brenntag Biosector (Denmark) was the global leader in the vaccine adjuvants market in 2015. The company is a subsidiary of Brenntag AG (Germany). It is a well-known company and has an exhaustive product portfolio. The company is innovation-centric and invests heavily in R&D for maintaining its market share. The company also focuses on inorganic growth strategies such as agreements to enhance its market share. For instance, Brenntag Biosector A/S (Denmark) signed an agreement with MoreinX AB (Sweden) for the commercialization of nanoparticle-based vaccine adjuvants. This agreement helped expand the company’s novel offerings for vaccine adjuvants in the market.
Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894
SEPPIC (France) held the second position in the vaccine adjuvants market in 2015. This can be attributed to the company’s strong portfolio of vaccine adjuvants. The company adopts organic growth strategies such as expansions to boost its market share. For instance, SEPPIC (France) launched a production and sterile packaging unit for vaccine adjuvants and injectables by investing USD 6.66 million in Castres, France. This facility launched helped expand the company’s production capacity in the vaccine adjuvants market and enabled it to become the first company to introduce packaging of veterinary vaccine adjuvants in large volumes.
The key strategies followed by most companies in the vaccine adjuvants market are inorganic strategies such as partnerships, agreements, and collaborations; mergers and acquisitions; and expansions. The strategy of partnerships, agreements, and collaborations accounted for the largest share of the overall growth strategies mapped from 2013 to 2016. Some of the leading players that adopted this strategy include Brenntag Biosector (Denmark), CSL Limited (Australia), and SEPPIC (France). Mergers & acquisitions accounted for the second-largest share of the overall growth strategies adopted by players in this market.

Related Links:
https://www.marketsandmarkets.com/PressReleases/vaccine-adjuvants.asp
https://www.marketsandmarkets.com/ResearchInsight/vaccine-adjuvants-market.asp
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com